# Chas Pulido

> Chas Pulido is a startup investor at Alix Ventures (San Francisco). See 0 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Alix Ventures](https://shizune.co/investors/profile/alix-ventures)
- Location: San Francisco, United States
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/chas-pulido-1b858584/

Chas Pulido is a startup investor at Alix Ventures in San Francisco. Chas Pulido is the Founder and General Partner at Alix Ventures. He attended the University of Notre Dame.

## About Alix Ventures

VC Fund · San Francisco, United States

Alix Ventures: Driving Patient Impact - Supporting Early Stage Life Science Startups Engineering Biology to Drive Radical Advances in Human HealthBorn from our collective experience as founders, we set out to build the fund we wanted to raise from...Thesis: Life Sciences is experiencing rapid innovation with the rise of TechBio, a change webelieve is leading to some of the most impactful solutions in decades. Our passion is to help build transformative companies ahead of this revolution to significantly impact the quality & effectiveness of patient care. We aim to partner with passionate, accomplished founders who possess unique insights to solve some of the world’s most daring problems facing us in Life Sciences.Team: Our entire team is composed of serial VC backed Life Sciences founders with experience in raising capital, scaling teams, running labs, navigating regulatory mazes, partnering with pharma & the many fires that consist of operating an early stage company. We’ve been in your shoes before, we pride ourselves in being the VC we wish we had on our own cap tables, founders we are here to help! SAB/MAB: Composed of top VC-backed PhD Life Sciences founders, our scientific & medical advisory board aids our investment team in both technical & clinical diligence - thus providing a multitude of expertise & fluency across a wide variety of Life Science sub-domains. Let’s talk science!Support: Helping our founders is our utmost priority. To tackle the many challenges ahead, we’ve curated a full platform of resources to help with customer introductions, fundraising, & team building, amongst others. In addition, dedicated to supporting our portfolio is our operating partner - Mark Pulido (5x HC/LS CEO - previously of Novartis, McKesson, & Ability) & our extensive network of industry executives spanning Top 25 Pharma, major health systems, & large payors.Limited Partners: Anchored by leading strategic LPs making up some of the best venture capital firms in the world, veteran founders, & industry experts. Alix is here to fill the void for early stage Life Sciences specific capital in Silicon Valley.

1 contacts available at Alix Ventures.

| Name | Title | Profile |
| --- | --- | --- |
| Chas Pulido | Founder and General Partner | https://shizune.co/investors/profile/chas-pulido |

## FAQ

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co